130432-39-2Relevant articles and documents
Ethynylbenziodoxolones (EBX) as reagents for the ethynylation of stabilized enolates
Fernandez Gonzalez, Davinia,Brand, Jonathan P.,Mondiere, Regis,Waser, Jerome
supporting information, p. 1631 - 1639 (2013/07/05)
Herein, we report a detailed study on the electrophilic alkynylation of cyclic keto esters and amides with ethynylbenziodoxolone (EBX) reagents. The structure and stability of this class of reagents is first described more in details. Differential scannin
Straightforward synthesis of chiral hydroxy isocyanides
Bauer, Michael,Kazmaier, Uli
experimental part, p. 2360 - 2366 (2009/09/05)
Various types of hydroxy isocyanides have been prepared from the corresponding amino alcohols. These hydroxy isocyanides are interesting building blocks for multicomponent reactions and the synthesis of (hydroxyalkyl) oxazoline ligands. The isocyanides ar
Synthesis of chiral tetraaminophosphonium chlorides from N-Boc α-amino acid esters
Uraguchi, Daisuke,Sakaki, Sawako,Ueki, Yusuke,Ito, Takaki,Ooi, Takashi
scheme or table, p. 1081 - 1085 (2009/06/28)
Preparation of chiral tetraaminophosphonium chlorides of type 1 starting from N-Boc α-amino acid esters is described. Modified conditions for the displacement of the tertiary hydroxy group of the intermediary amino alcohol pave a way for the assembly of 1
Orally Bioavailable Caffeic Acid Related Anticancer Drugs
-
Page/Page column 18, (2008/06/13)
The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as inhibitors of Jak2/STAT3 pathways and downstream targets and inhibit the growth and survival of cancerous cell lines.